Home  >  Research  >  Labs  >  Genome Biology and Genetic Diseases Program


The Genome Biology and Genetics Diseases Program at the Perkins is lead by Professor Ryan Lister. The program focuses on factors that affect health and well being at the genetic, protein and population levels, with the common aim of improving diagnosis and treatment of disease.

Professor Ryan Lister

Professor Ryan Lister

Epigenetics and Genomics (Program Head - Genome Biology and Genetics)

Read more


Perkins Researchers Rebooting Evolution

The building blocks of life-saving therapeutics could be developed in days instead of years thanks to new software that simulates evolution. Proseeker is the name of a new computational tool…

Read More

Double hit of new appointments for Head of Molecular Endocrinology and Pharmacology

Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) earlier this month. Coincidentally, on…

Read More

$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease

Biopharmaceutical company, Dimerix (ASX: DXB), which is developing new treatments for types of inflammatory kidney and respiratory diseases, announced it has successfully raised $20 million to fund Phase 3 trials…

Read More

Help WA's best medical researchers beat the world's toughest diseases.